about
Antiepileptic treatment in paediatric oncology--an interdisciplinary challenge.Use of positron emission tomography for staging, preoperative response assessment and posttherapeutic evaluation in children with Wilms tumour.Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study.Brain metastases in children and adolescents with extracranial germ cell tumor - data of the MAHO/MAKEI-registry.FDG-PET Response Prediction in Pediatric Hodgkin's Lymphoma: Impact of Metabolically Defined Tumor Volumes and Individualized SUV Measurements on the Positive Predictive Value.DICER1 hotspot mutations in non-epithelial gonadal tumours.Explorative analyses on the value of interim PET for prediction of response in pediatric and adolescent non-Hodgkin lymphoma patients.Familial rhabdoid tumour 'avant la lettre'--from pathology review to exome sequencing and back again.EPCAM-A novel molecular target for the treatment of pediatric and adult germ cell tumors.Cat scratch disease--heterogeneous in clinical presentation: five unusual cases of an infection caused by Bartonella henselae.Survival after an antiangiogenetic therapy and surgery in a wide spread growing teratoma originating from a testicular mixed malignant germ cell tumor.Theranostics in nuclear medicine practiceAssessment of histological response of paediatric bone sarcomas using FDG PET in comparison to morphological volume measurement and standardized MRI parameters.Prospective, comprehensive, and effective viral monitoring in children undergoing allogeneic hematopoietic stem cell transplantation.Early and late therapy response assessment with [18F]fluorodeoxyglucose positron emission tomography in pediatric Hodgkin's lymphoma: analysis of a prospective multicenter trial.Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial.Brentuximab vedotin exerts profound antiproliferative and pro-apoptotic efficacy in CD30-positive as well as cocultured CD30-negative germ cell tumour cell lines.Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.Whole-genome paired-end analysis confirms remarkable genomic stability of atypical teratoid/rhabdoid tumors.The FDA approved PI3K inhibitor GDC-0941 enhances in vitro the anti-neoplastic efficacy of Axitinib against c-myc-amplified high-risk medulloblastoma.RAG1 deficiency with a shifting B cell phenotype and chromosomal instability.Saving the red baby: successful allogeneic cord blood transplantation in Omenn syndrome.Novel acid-labile subunit ( IGFALS ) mutation p.T145K (c.434C>A) in a patient with ALS deficiency, normal stature and immunological dysfunction.SUV-measurements and patient-specific corrections in pediatric Hodgkin-lymphoma: is there a benefit for PPV in early response assessment by FDG-PET?Testicular germ cell tumors in boys <10 years: results of the protocol MAHO 98 in respect to surgery and watch & wait strategy.Evaluation of interim PET response criteria in paediatric Hodgkin's lymphoma--results for dedicated assessment criteria in a blinded dual-centre read.Infancy-Onset T1DM, Short Stature, and Severe Immunodysregulation in Two Siblings With a Homozygous LRBA Mutation.Three cases of renal relapse after allogeneic hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia.Molecular genetic analysis of bilateral ovarian germ cell tumors.Analysis of the adenomatous polyposis coli (APC) gene in childhood and adolescent germ cell tumors.Genotype and protein expression after bone marrow transplantation for adrenoleukodystrophyComparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignanciesTesticular germ cell tumors in adolescents - results of the protocol MAHO 98 and the identification of good risk patientsMesenchymal stem cells as cellular immunotherapeutics in allogeneic hematopoietic stem cell transplantationAge-Dependent Presentation and Clinical Course of 1465 Patients Aged 0 to Less than 18 Years with Ovarian or Testicular Germ Cell Tumors; Data of the MAKEI 96 Protocol Revisited in the Light of Prenatal Germ Cell BiologyTargeting EpCAM by a Bispecific Trifunctional Antibody Exerts Profound Cytotoxic Efficacy in Germ Cell Tumor Cell Lines
P50
Q33262413-A74A8099-FB6F-4D2D-AF68-38162AA425D0Q33338527-069AB54D-3732-4282-BC07-6738E02A9187Q33408859-50ACC3A1-EAB6-44E7-B9E9-28C157EC1FBFQ33591419-0926B411-306B-4A65-8B85-44D56C456532Q35237507-7FABE82C-3EDE-4FFC-8E5F-FB488ED46F40Q37323053-7BA19132-CC87-4410-92B1-4F8BED4B97B4Q37369885-0C3A7DBC-4F2F-4E81-9106-2FAB88BE940BQ38115209-82647B07-FF2C-4847-933F-DA946D119172Q39276591-61F298AB-D35C-4643-AEE2-168A539EA0DEQ40378553-0DAAEF42-CABD-42E2-B979-556724D74E0EQ42167806-6E3DB903-059A-4A8A-87AD-C19A6B801168Q42373162-F5CC7A54-CE8D-42E9-A786-152AD3C2E68EQ43053307-B5138E16-2605-4E55-9800-1C593FF1BF87Q43095303-439099F5-FF64-489E-9FA8-D33F598D0624Q43295120-0E0BAB8E-4A18-4620-8D58-A26DD87EBF75Q44001368-921191AF-AEAA-4765-B0AE-742BA0C0824BQ46874365-62F3508B-ABD9-49B5-B7B8-966EF32DF5F5Q47098861-9DD2DA33-CB72-4358-85C4-3AE81B4ECC64Q47278215-66D65002-45F7-4083-9295-22FF53C41CE9Q47821730-78A48248-61EE-4AFC-9C26-1D272250F28DQ48150834-F297AB56-C05D-4759-829F-BFC9451ED725Q50478127-6E853F10-8B4E-4EB8-9098-108D8270444DQ50625704-2A32EE1A-176B-4ECB-88EF-F943EFF0990FQ51330598-B983924F-E55F-4E5E-9812-0B43018568ACQ51373515-D0B6A76A-8A4F-4832-BEEB-EE66FE807458Q51775285-1E6A7598-8393-446F-8EE7-16CB11221838Q53075673-E44D621F-A476-48AB-AC12-5520BC66AA8AQ53329154-1F40177A-6F2B-4E2E-97B0-EF8D270C77D4Q53537525-0EE3EBC4-8BBA-41E0-A012-00687AB39E1FQ54284102-07B94A5C-1EF1-419C-AA37-5874B0EC26A6Q54372325-C24B38F7-4B73-4C6C-85A7-D051C26E3001Q79923674-39810660-50A9-4CDA-9130-83959F52E11AQ81471277-E5AFD32B-9415-429F-990F-B7F1831F95D8Q86075355-2CAF37BB-D1EF-4894-9EB6-B7A48F398902Q86254126-BFACAA77-FE9D-49A8-AF96-40ADDC8F5B3EQ90189953-D66EB459-B7DB-4586-8871-CA8821564C13Q95302912-B5445DB3-39A0-47F3-84DF-BC710847D52E
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Stefan Schönberger
@ast
Stefan Schönberger
@en
Stefan Schönberger
@es
Stefan Schönberger
@nl
Stefan Schönberger
@sl
type
label
Stefan Schönberger
@ast
Stefan Schönberger
@en
Stefan Schönberger
@es
Stefan Schönberger
@nl
Stefan Schönberger
@sl
prefLabel
Stefan Schönberger
@ast
Stefan Schönberger
@en
Stefan Schönberger
@es
Stefan Schönberger
@nl
Stefan Schönberger
@sl
P106
P21
P31
P496
0000-0002-7222-296X